 BOULDER, Colo.--BUSINESS WIRE--- CLVS--Clovis Oncology, Inc. NASDAQ: CLVS will announce its second quarter 2022 financial results and provide an update on its clinical development programs and regulatory and business outlook on Monday, August 8, 2022, before the open of the US financial markets. Clovis senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis results and business outlook in greater detail. The conference call will be simultaneously webcas 